Avalon GloboCare (NASDAQ:AVCO) and GE Healthcare (NYSE:GE) Partner to Advance Cellular Therapies
Avalon GloboCare Corp. (NASDAQ:AVCO) announced a strategic partnership with GE Healthcare (NYSE:GE) on July 22. The deal is designed to accelerate Avalon's standardization, automation and bio-production for CAR-T cells and other cellular therapies related to immunotherapy. This includes exosomes/extracellular vesicles (EV)-based regenerative therapeutics.
View full press release